A phase 3 clinical trial to evaluate the efficacy and safety of a topical investigational medication (LEO 43204 gel 0.037%) for the treatment of Actinic Keratosis (sun spots) on balding scalp.

To determine the safety and effectiveness of LEO 43204 gel on sun spots of the balding scalp

Primary Sponsor:
Leo Pharma

Prinicipal Investigator:
Allison Ehrlich, MD

Are you interested in more information on this clinical trial?

First Name *
Last Name *
Email *
Street Address *
City *
State *
Zip Code *
Phone Number 
Verification Code *

Please type what you see (all uppercase):